Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of tumor growth by NF‐κB inhibitors

22 Aug 2006

Abstract excerpt

NF-kappaB is a transcription factor that induces inflammatory cytokines and anti-apoptotic proteins. NF-kappaB is often constitutively activated in human cancers and leukemias, which might increase the malignant character of neoplastic diseases. Therefore, NF-kappaB inhibitors might be useful as anticancer agents. Our research team designed a new NF-kappaB inhibitor that is based on the structure of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Natural Compounds in Disease Treatment
Share to Natural product bioactivities and synthesis
Share to NF-κB Signaling Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16925581
DOI: 10.1111/j.1349-7006.2006.00285.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of tumor growth by NF‐κB inhibitorsPMID 16925581Read ↗

An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathwaySemantic proximity Read ↗

The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable TargetSemantic proximity Read ↗

Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of ViewSemantic proximity Read ↗

Nuclear Factor-κB in Development, Prevention, and Therapy of CancerSemantic proximity Read ↗

Small Molecule NF-κB Pathway Inhibitors in ClinicSemantic proximity Read ↗

Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 PathwaysSemantic proximity Read ↗

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancerSemantic proximity Read ↗

Transcription Factor NF-κB: An Update on Intervention StrategiesSemantic proximity Read ↗

Nuclear Factor-κB Activation: From Bench to BedsideSemantic proximity Read ↗

Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)Semantic proximity Read ↗

NF-κB in the crosshairs: Rethinking an old riddleSemantic proximity Read ↗

NF-κB in cancer therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.